Povorcitinib
Modify Date: 2025-08-26 23:01:25
Povorcitinib structure
|
Common Name | Povorcitinib | ||
|---|---|---|---|---|
| CAS Number | 1637677-22-5 | Molecular Weight | 507.46 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H22F5N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PovorcitinibPovorcitinib is a potent and selective inhibitor of JAK1. Povorcitinib has the potential for the research of disease selected from cutaneous lupus erythematosus (CLE) and Lichen planus (LP) (extracted from patent WO2021076124A1)[1]. |
| Name | Povorcitinib |
|---|
| Description | Povorcitinib is a potent and selective inhibitor of JAK1. Povorcitinib has the potential for the research of disease selected from cutaneous lupus erythematosus (CLE) and Lichen planus (LP) (extracted from patent WO2021076124A1)[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK1[1] |
| References |
| Molecular Formula | C23H22F5N7O |
|---|---|
| Molecular Weight | 507.46 |